2-48646471-A-T

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_006872.5(GTF2A1L):​c.407A>T​(p.Asn136Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000267 in 1,608,826 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N136S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00014 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000015 ( 0 hom. )

Consequence

GTF2A1L
NM_006872.5 missense

Scores

1
9
9

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.66
Variant links:
Genes affected
GTF2A1L (HGNC:30727): (general transcription factor IIA subunit 1 like) The assembly and stability of the RNA polymerase II transcription pre-initiation complex on a eukaryotic core promoter involve the effects of transcription factor IIA (TFIIA) on the interaction between TATA-binding protein (TBP) and DNA. This gene encodes a germ cell-specific counterpart of the large (alpha/beta) subunit of general transcription factor TFIIA that is able to stabilize the binding of TBP to DNA and may be uniquely important to testis biology. Alternative splicing for this locus has been observed and two variants, encoding distinct isoforms, have been identified. Co-transcription of this gene and the neighboring upstream gene generates a rare transcript (SALF), which encodes a fusion protein comprised of sequence sharing identity with each individual gene product. [provided by RefSeq, Mar 2014]
STON1-GTF2A1L (HGNC:30651): (STON1-GTF2A1L readthrough) STON1-GTF2A1L mRNAs are infrequent but naturally occurring read-through products of the neighboring STON1 and GTF2A1L genes. These transcripts encode fusion proteins composed of the vast majority of each of the individual elements, stonin 1 and general transcription factor IIA, 1-like. Alternative splicing results in multiple transcript variants. The significance of these read-through variants and the function of the resulting protein products have not yet been determined. [provided by RefSeq, Oct 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.16877964).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GTF2A1LNM_006872.5 linkc.407A>T p.Asn136Ile missense_variant Exon 6 of 9 ENST00000403751.8 NP_006863.2 Q9UNN4-1A0A140VKA3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GTF2A1LENST00000403751.8 linkc.407A>T p.Asn136Ile missense_variant Exon 6 of 9 1 NM_006872.5 ENSP00000384597.3 Q9UNN4-1
STON1-GTF2A1LENST00000394754.5 linkc.2519A>T p.Asn840Ile missense_variant Exon 8 of 11 1 ENSP00000378236.1 Q53S48
ENSG00000279956ENST00000602369.3 linkn.*551T>A non_coding_transcript_exon_variant Exon 12 of 13 5 ENSP00000473498.1 R4GN57
ENSG00000279956ENST00000602369.3 linkn.*551T>A 3_prime_UTR_variant Exon 12 of 13 5 ENSP00000473498.1 R4GN57

Frequencies

GnomAD3 genomes
AF:
0.000138
AC:
21
AN:
152026
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000435
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000197
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000738
AC:
18
AN:
243740
AF XY:
0.0000379
show subpopulations
Gnomad AFR exome
AF:
0.000621
Gnomad AMR exome
AF:
0.000239
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000151
AC:
22
AN:
1456800
Hom.:
0
Cov.:
32
AF XY:
0.00000828
AC XY:
6
AN XY:
724706
show subpopulations
African (AFR)
AF:
0.000332
AC:
11
AN:
33104
American (AMR)
AF:
0.000207
AC:
9
AN:
43436
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25722
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39676
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85266
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53292
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5710
European-Non Finnish (NFE)
AF:
0.00000180
AC:
2
AN:
1110454
Other (OTH)
AF:
0.00
AC:
0
AN:
60140
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.423
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000138
AC:
21
AN:
152026
Hom.:
0
Cov.:
32
AF XY:
0.000108
AC XY:
8
AN XY:
74272
show subpopulations
African (AFR)
AF:
0.000435
AC:
18
AN:
41386
American (AMR)
AF:
0.000197
AC:
3
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4816
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10588
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68016
Other (OTH)
AF:
0.00
AC:
0
AN:
2082
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000126
Hom.:
0
Bravo
AF:
0.000159
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000741
AC:
9

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 23, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.407A>T (p.N136I) alteration is located in exon 6 (coding exon 6) of the GTF2A1L gene. This alteration results from a A to T substitution at nucleotide position 407, causing the asparagine (N) at amino acid position 136 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.35
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.30
CADD
Benign
23
DANN
Uncertain
0.98
DEOGEN2
Benign
0.33
.;.;.;.;.;.;.;T
Eigen
Uncertain
0.29
Eigen_PC
Benign
0.20
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.88
.;D;D;D;D;D;D;D
M_CAP
Benign
0.036
D
MetaRNN
Benign
0.17
T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.80
T
MutationAssessor
Pathogenic
3.0
.;.;.;.;.;.;.;M
PhyloP100
1.7
PrimateAI
Benign
0.36
T
PROVEAN
Uncertain
-2.8
D;D;D;D;D;D;D;D
REVEL
Uncertain
0.30
Sift
Uncertain
0.0010
D;D;D;D;D;D;D;D
Sift4G
Uncertain
0.0030
D;D;D;D;D;D;D;D
Polyphen
1.0
D;.;D;.;.;.;D;D
Vest4
0.73
MVP
0.37
MPC
0.010, 0.029
ClinPred
0.35
T
GERP RS
0.34
Varity_R
0.51
gMVP
0.78
Mutation Taster
=70/30
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147234215; hg19: chr2-48873610; API